728 x 90
728 x 90



  • Covid-19 Vaccines: A Timeline of Recent Advancements

    Covid-19 Vaccines: A Timeline of Recent Advancements0

    Images Credit: Mos.ru, CC BY 4.0, via Wikimedia Commons, Rs-nourse, CC BY-SA 4.0, via Wikimedia Commons,https://en.wikipedia.org/wiki/File:Moderna_Therapeutics_company_logo.png with UploadWizard, CC BY-SA 3.0 Press Releases: Sputnik: https://sputnikvaccine.com/newsroom/pressreleases/second-interim-analysis-of-clinical-trial-data-showed-a-91-4-efficacy-for-the-sputnik-v-vaccine-on-d/ AstraZeneca: https://www.ox.ac.uk/news/2020-11-23-oxford-university-breakthrough-global-covid-19-vaccine FDA: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-announces-advisory-committee-meeting-discuss-covid-19-vaccine Pfizer: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine Moderna: https://investors.modernatx.com/news-releases/news-release-details/modernas-covid-19-vaccine-candidate-meets-its-primary-efficacy

    READ MORE
  • Weekly Roundup: Vaccines On the Way, Long-Lasting Immunity, and More

    Weekly Roundup: Vaccines On the Way, Long-Lasting Immunity, and More0

    Phase 3 is over: Pfizer’s Vaccine is 95% effective against Covid-19 On November 18, Pfizer and the German manufacturer BioNTech shared the phase 3 results from the BNT162b2 vaccine candidate. The mRNA-based COVID-19 vaccine met all the efficacy endpoints across different ages, gender, races, and ethnicities. The vaccine’s overall efficacy is 95%, and the reported side-effects

    READ MORE
  • The First Record of a SARS-CoV2 Infection Dates to One Year Ago Today

    The First Record of a SARS-CoV2 Infection Dates to One Year Ago Today0

    A 55-year-old resident of Hubei, China, may have been the first registered case of the novel coronavirus infection. The record dates to one year ago today, on the 17th of November 2019, according to Chinese official data revealed by The South China Morning Post. But the search for “patient zero” is far from over. Without

    READ MORE